EHS
EHS

D1 Antagonist Pipeline Insight, 2018 Report Featuring Alkermes, Delpor, Fabre-Kramer Pharmaceuticals, Eli Lilly & Schering-Plough – ResearchAndMarkets.com




DUBLIN–(BUSINESS WIRE)–The "D1 Antagonist -Pipeline Insight, 2018" drug pipelines has been added to ResearchAndMarkets.com's offering. D1 Antagonist – Pipeline Insight, 2018' report offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across D1 Antagonist development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by de

Source link

EHS
Back to top button